Literature DB >> 30105924

Tanshinone IIA Activates Nuclear Factor-Erythroid 2-Related Factor 2 to Restrain Pulmonary Fibrosis via Regulation of Redox Homeostasis and Glutaminolysis.

Lin An1, Li-Ying Peng1, Ning-Yuan Sun1, Yi-Lin Yang1, Xiao-Wei Zhang1, Bin Li1, Bao-Lin Liu1, Ping Li1, Jun Chen1.   

Abstract

AIMS: Pulmonary fibrosis (PF) is characterized by myofibroblast activation through oxidative stress. However, the precise regulation of myofibroblast transdifferentiation remains largely uncharacterized.
RESULTS: In this study, we found that tanshinone IIA (Tan-IIA), an active component in the root of Salvia miltiorrhiza Bunge, can suppress reactive oxygen species (ROS)-mediated activation of myofibroblast and reduce extracellular matrix deposition in bleomycin (BLM)-challenged mice through the regulation of nuclear factor-erythroid 2-related factor 2 (Nrf2). Additionally, Tan-IIA restored redox homeostasis by upregulating Nrf2 with NADPH oxidase 4 suppression and effectively prevented myofibroblast activation by blocking ROS-mediated protein kinase C delta (PKCδ)/Smad3 signaling. Nrf2 knockdown in the fibroblasts and the lungs of BLM-treated mice reduced the inhibitory effects of Tan-IIA, indicating the essential role of Nrf2 in the Tan-IIA activity. Tan-IIA impaired the binding of kelch-like ECH-associated protein 1 (Keap1) to Nrf2 by promoting the degradation of Keap1 and thereby increasing Nrf2 induction by protecting Nrf2 stability against ubiquitination and proteasomal degradation. Importantly, we also found that the glutamate anaplerotic pathway was involved in energy generation and biosynthesis in activated myofibroblasts and their proliferation. Tan-IIA shunted glutaminolysis into glutathione (GSH) production by activating Nrf2, resulting in the reduction of glutamate availability for tricarboxylic acid cycle. Ultimately, myofibroblast activation was prevented by impairing cell proliferation. Innovation and
Conclusion: In addition to the regulation of redox homeostasis, our work showed that Tan-IIA activated Nrf2/GSH signaling pathway to limit glutaminolysis in myofibroblast proliferation, which provided further insight into the critical function of Nrf2 in PF.

Entities:  

Keywords:  Nox4; Nrf2; glutaminolysis; myofibroblast activation; pulmonary fibrosis; tanshinone IIA

Mesh:

Substances:

Year:  2018        PMID: 30105924     DOI: 10.1089/ars.2018.7569

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  8 in total

1.  Dysregulation of iron homeostasis and methamphetamine reward behaviors in Clk1-deficient mice.

Authors:  Peng-Ju Yan; Zhao-Xiang Ren; Zhi-Feng Shi; Chun-Lei Wan; Chao-Jun Han; Liu-Shuai Zhu; Ning-Ning Li; John L Waddington; Xue-Chu Zhen
Journal:  Acta Pharmacol Sin       Date:  2021-11-22       Impact factor: 7.169

2.  DNA Methylome and Transcriptome Alterations in High Glucose-Induced Diabetic Nephropathy Cellular Model and Identification of Novel Targets for Treatment by Tanshinone IIA.

Authors:  Wenji Li; Davit Sargsyan; Renyi Wu; Shanyi Li; Lujing Wang; David Cheng; Ah-Ng Kong
Journal:  Chem Res Toxicol       Date:  2019-09-17       Impact factor: 3.739

3.  NADPH Oxidase Inhibition in Fibrotic Pathologies.

Authors:  Karen Bernard; Victor J Thannickal
Journal:  Antioxid Redox Signal       Date:  2020-03-04       Impact factor: 7.468

4.  Tanshinone IIA Protects against Acute Pancreatitis in Mice by Inhibiting Oxidative Stress via the Nrf2/ROS Pathway.

Authors:  Weiwei Chen; Chenchen Yuan; Yingying Lu; Qingtian Zhu; Xiaojie Ma; Weiming Xiao; Weijuan Gong; Wei Huang; Qing Xia; Guotao Lu; Weiqin Li
Journal:  Oxid Med Cell Longev       Date:  2020-04-08       Impact factor: 6.543

Review 5.  Therapeutic Effect of Tanshinone IIA on Liver Fibrosis and the Possible Mechanism: A Preclinical Meta-Analysis.

Authors:  Qingji Ying; Yangyang Teng; Jing Zhang; Zhenzhai Cai; Zhanxiong Xue
Journal:  Evid Based Complement Alternat Med       Date:  2019-12-13       Impact factor: 2.629

Review 6.  Nrf2 Signaling Pathway in Chemoprotection and Doxorubicin Resistance: Potential Application in Drug Discovery.

Authors:  Sepideh Mirzaei; Ali Zarrabi; Farid Hashemi; Amirhossein Zabolian; Hossein Saleki; Negar Azami; Soodeh Hamzehlou; Mahdi Vasheghani Farahani; Kiavash Hushmandi; Milad Ashrafizadeh; Haroon Khan; Alan Prem Kumar
Journal:  Antioxidants (Basel)       Date:  2021-02-26

Review 7.  Targeting Oxidative Stress as a Therapeutic Approach for Idiopathic Pulmonary Fibrosis.

Authors:  Cristina Estornut; Javier Milara; María Amparo Bayarri; Nada Belhadj; Julio Cortijo
Journal:  Front Pharmacol       Date:  2022-01-21       Impact factor: 5.810

Review 8.  Salvia miltiorrhiza in thorax and abdomainal organ fibrosis: A review of its pharmacology.

Authors:  Zhao Yang; Jingshu Qi; Dabing Ping; Xin Sun; Yanyan Tao; Chenghai Liu; Yuan Peng
Journal:  Front Pharmacol       Date:  2022-09-20       Impact factor: 5.988

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.